0001179110-17-002931.txt : 20170222 0001179110-17-002931.hdr.sgml : 20170222 20170222173419 ACCESSION NUMBER: 0001179110-17-002931 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20170217 FILED AS OF DATE: 20170222 DATE AS OF CHANGE: 20170222 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: ABBOTT LABORATORIES CENTRAL INDEX KEY: 0000001800 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 360698440 STATE OF INCORPORATION: IL FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 100 ABBOTT PARK ROAD STREET 2: D-322 AP6D CITY: ABBOTT PARK STATE: IL ZIP: 60064-3500 BUSINESS PHONE: 8479376100 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: NATH DEEPAK S. CENTRAL INDEX KEY: 0001636628 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-02189 FILM NUMBER: 17629738 MAIL ADDRESS: STREET 1: 100 ABBOTT PARK ROAD STREET 2: AP6A-2, D-032L CITY: ABBOTT PARK STATE: IL ZIP: 60064-6092 4 1 edgar.xml FORM 4 - X0306 4 2017-02-17 0 0000001800 ABBOTT LABORATORIES ABT 0001636628 NATH DEEPAK S. 100 ABBOTT PARK ROAD ABBOTT PARK IL 60064-6400 0 1 0 0 Senior Vice President Common shares without par value 2017-02-17 4 A 0 11089 0 A 58471 D Common shares without par value 2017-02-21 4 F 0 819 44.69 D 57652 D Common shares without par value 2017-02-21 4 S 0 319 44.981 D 57333 D Option (right to buy) 44.40 2017-02-17 4 A 0 76693 0 A 2018-02-17 2027-02-16 Common shares 76693 76693 D These shares represent performance vested restricted stock awards under the Abbott Laboratories 2009 Incentive Stock Program. The awards have a 5-year term, with no more than 1/3 of the award vesting in any one year upon Abbott reaching a minimum return on equity target. The awards include the right to have stock withheld for tax purposes. Employee stock option granted pursuant to the Abbott Laboratories 2009 Incentive Stock Program in a transaction exempt from Section 16 under Rule 16b-3. The option becomes exercisable in annual increments of 25,565 on 2/17/2018, 25,564 on 2/17/2019, and 25,564 on 2/17/2020. The sale transaction was made pursuant to a previously adopted plan complying with Rule 10b5-1(c). John A. Berry, by power of attorney for Deepak S. Nath 2017-02-22